Back to top
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Intuitive Surgical (ISRG) A Buy Ahead of Q2 Earnings Announcement?
Medical instrument provider Intuitive Surgical (ISRG - Free Report) is set to report second-quarter earnings results on Thursday after the bell. The maker of the popular da Vinci Surgical System, Intuitive Surgical is a Zacks Rank #2 (Buy) stock. The established health care company has missed the earnings mark in two of the last four quarters. But with sales and earnings estimates projecting significant year-over-year increases, is ISRG a buy?
Intuitive Surgical is expected to post a profit of $1.32/share, which would reflect solid growth of 15.79% versus the same quarter last year. Estimates for the quarter have remained steady over the past 60 days. Revenues are projected to rise 13.82% to $1.73 billion.
ISRG stock has surged nearly 34% this year. The health care giant is currently showing a negative Zacks Earnings ESP (Expected Surprise Prediction) of -1.29%. As such, our proprietary Zacks Model does not conclusively predict an earnings beat for the upcoming announcement.